My Treatment Approach: Evolving Treatment Strategies in Metastatic Melanoma

A group of oncology experts discusses the adjuvant treatment of melanoma, providing expert insights into the management of immunotherapy-related endocrine and cardiac toxicities, with a case discussion to emphasize these important topics.

EP. 1: An Overview of the Landscape Surrounding Melanoma

December 22nd 2023

Nikhil Khushalani, MD, offers a brief overview of the landscape surrounding melanoma, encompassing key aspects such as incidence rates and prognosis.

EP. 2: The Role of Biomarker Testing in Melanoma

January 5th 2024

Nikhil Khushalani, MD, explores the significance of biomarker testing in melanoma, emphasizing the pivotal role of BRAF in understanding and managing this type of skin cancer.

EP. 3: The Current Landscape Surrounding Adjuvant Therapy in Melanoma

January 12th 2024

Nikhil Khushalani, MD, provides a thorough exploration of the current treatment landscape in adjuvant therapy for melanoma, presenting insights into advancing strategies and developments in the field, while also discussing key findings from the CheckMate 238 and KEYNOTE-054 trials.

EP. 4: Combination Immunotherapy Strategies for Melanoma in the Adjuvant Setting

January 12th 2024

Nikhil Khushalani, MD, delves into the role of combination immunotherapy strategies for melanoma in the adjuvant setting, providing insights into the specific details and outcomes of the IMMUNED trial.

EP. 5: Navigating Challenges in Predicting and Mitigating Adverse Events in Adjuvant Immunotherapy

January 19th 2024

Nikhil Khushalani, MD, navigates the challenges associated with predicting and mitigating adverse events in adjuvant immunotherapy, offering valuable insights into strategies for addressing potential complications in this treatment approach.

EP. 6: Exploring Immunotherapy Resistance: Impact on Treatment Decisions in Melanoma

January 19th 2024

Nikhil Khushalani, MD, examines immunotherapy resistance in melanoma treatment, providing valuable insights into navigating challenges and its impact on treatment decisions.

EP. 7: Balancing Quality of Life: Adjuvant Therapy Toxicity in Melanoma Adjuvant Immunotherapy

January 26th 2024

A panel of oncology experts explores the intricate balance between maintaining quality of life and managing toxicity in adjuvant immunotherapy for melanoma.

EP. 8: Case 1: Man Aged 55 Years With Stage IIIB Melanoma Developing Immunotherapy-Induced Diabetes

January 26th 2024

Afreen Shariff, MD, MBBS, introduces case 1, involving a 55-year-old man with stage IIIB melanoma who develops immunotherapy-induced diabetes.

EP. 9: Immunotherapy-Related Diabetes in Melanoma: A Management Perspective

February 2nd 2024

Afreen Shariff, MD, MBBS, discusses managing immunotherapy-related diabetes in melanoma, emphasizing the critical need to detect sudden changes in blood sugar levels and advocating for a multidisciplinary approach.

EP. 10: Immunotherapy-Induced Adrenal Insufficiency in Melanoma: Surveillance and Management

February 2nd 2024

Afreen Shariff, MD, MBBS, examines the surveillance and management of immunotherapy-induced adrenal insufficiency in the context of melanoma, underscoring the importance of maintaining a heightened awareness for early detection.